tiprankstipranks
Trending News
More News >
Nanobiotix SA (GB:0QAV)
LSE:0QAV

Compare Nanobiotix (0QAV) vs. Competitors

Compare
4 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Nanobiotix
€18.22
€844.82M
418.43%
1 Buy
0 Hold
0 Sell
Moderate Buy
Genfit
€5.60
€279.62M
-7.19
52.17%
1 Buy
0 Hold
0 Sell
Moderate Buy
Innate Pharma SA
€1.62
€145.08M
-2.82
-11.34%
Abivax SA
€95.90
€7.44B
-33.91
1514.99%
1 Buy
0 Hold
0 Sell
Moderate Buy
DBV Technologies
€3.80
€763.63M
-4.01
369.17%
1 Buy
0 Hold
0 Sell
Moderate Buy
OSE Immunotherapeutics SA
€4.98
€106.59M
-3.00
-28.54%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
GB:0QAV
Nanobiotix
17.98
14.47
412.22%
FR:GNFT
Genfit
5.60
2.02
56.64%
FR:IPH
Innate Pharma SA
1.55
-0.25
-14.00%
FR:ABVX
Abivax SA
94.80
88.76
1469.54%
FR:DBV
DBV Technologies
3.81
3.00
374.44%
FR:OSE
OSE Immunotherapeutics SA
4.75
-2.06
-30.22%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts